Brief: Fibrogen Inc - On June 12 Enters Termination, Asset Transfer And License Agreement With Hifibio
13/06/2025 21:21
June 13 (Reuters) - FibroGen Inc FGEN.O: FIBROGEN INC - ON JUNE 12 ENTERS TERMINATION, ASSET TRANSFER AND LICENSE AGREEMENT WITH HIFIBIO - SEC FILING FIBROGEN INC - AGREEMENT TERMINATES EXCLUSIVE LICENSE AND OPTION AGREEMENT - SEC FILING Further company coverage: FGEN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kyntra Bio
See all newsBrief: Kyntra Bio Appoints Andrew E. Singer, Mba To Its Board Of Directors
NASDAQ RESUMED AT 01:28 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:23 PM
Kyntra Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kyntra Bio swings to profit in Q2 on deconsolidation of subsidiary